Destiny Meda Tec Financials

DSNY

Source SEC Filings (10-K/10-Q) Updated Nov 30, 2025 Currency USD FYE August

This page shows Destiny Meda Tec (DSNY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 48/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Destiny Meda Tec has an operating margin of -14.7%, meaning the company retains $-15 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from 1.4% the prior year.

Growth

Destiny Meda Tec's revenue grew a modest 2.3% year-over-year to $4.5M. This slow but positive growth earns a score of 35/100.

Leverage

100

Destiny Meda Tec carries a low D/E ratio of 0.22, meaning only $0.22 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

100

With a current ratio of 4.00, Destiny Meda Tec holds $4.00 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Cash Flow

Destiny Meda Tec's free cash flow margin of 0.8% results in a low score of 4/100. Capital expenditures of $29K absorb a large share of operating cash flow.

Piotroski F-Score Neutral

4/9

Destiny Meda Tec passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Mixed

-0.10x

For every $1 of reported earnings, Destiny Meda Tec generates $-0.10 in operating cash flow ($65K OCF vs -$638K net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Revenue

$4.5M

YoY+2.3%

5Y CAGR+3.4%

10Y CAGR+3.1%

Destiny Meda Tec generated $4.5M in revenue in fiscal year 2025. This represents an increase of 2.3% from the prior year.

EBITDA

$171K

YoY-67.8%

5Y CAGR-9.5%

Destiny Meda Tec's EBITDA was $171K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 67.8% from the prior year.

Free Cash Flow

$36K

YoY-91.4%

5Y CAGR-29.6%

Destiny Meda Tec generated $36K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 91.4% from the prior year.

Net Income

-$638K

YoY-670.8%

Destiny Meda Tec reported -$638K in net income in fiscal year 2025. This represents a decrease of 670.8% from the prior year.

EPS (Diluted)

$-0.07

YoY-800.0%

Destiny Meda Tec earned $-0.07 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 800.0% from the prior year.

Cash & Debt

$1.1M

YoY-24.5%

5Y CAGR-9.5%

10Y CAGR+11.2%

Destiny Meda Tec held $1.1M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

10M

YoY+0.0%

5Y CAGR-1.6%

Destiny Meda Tec had 10M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Gross Margin

84.8%

YoY-1.4pp

5Y CAGR-6.8pp

Destiny Meda Tec's gross margin was 84.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.4 percentage points from the prior year.

Operating Margin

-14.7%

YoY-16.0pp

5Y CAGR-18.4pp

10Y CAGR+9.3pp

Destiny Meda Tec's operating margin was -14.7% in fiscal year 2025, reflecting core business profitability. This is down 16.0 percentage points from the prior year.

Net Margin

-14.1%

YoY-16.6pp

5Y CAGR-18.5pp

10Y CAGR+33.9pp

Destiny Meda Tec's net profit margin was -14.1% in fiscal year 2025, showing the share of revenue converted to profit. This is down 16.6 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$1.8M

YoY+16.5%

5Y CAGR+5.7%

10Y CAGR+2.5%

Destiny Meda Tec invested $1.8M in research and development in fiscal year 2025. This represents an increase of 16.5% from the prior year.

Share Buybacks

YoY-100.0%

Destiny Meda Tec spent $0 on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$29K

YoY+257.0%

5Y CAGR-14.6%

10Y CAGR-21.7%

Destiny Meda Tec invested $29K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 257.0% from the prior year.

DSNY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$4.5M+2.3%	$4.4M+9.6%	$4.0M+0.3%	$4.0M-3.6%	$4.2M+9.1%	$3.8M
Cost of Revenue	$687K+12.5%	$611K+18.5%	$515K-21.6%	$657K+66.7%	$394K+23.6%	$319K
Gross Profit	$3.8M+0.7%	$3.8M+8.3%	$3.5M+4.5%	$3.4M-10.9%	$3.8M+7.8%	$3.5M
R&D Expenses	$1.8M+16.5%	$1.5M+13.5%	$1.3M+21.6%	$1.1M-8.0%	$1.2M-11.0%	$1.3M
SG&A Expenses	$989K+41.6%	$698K-9.3%	$770K-21.5%	$980K+47.1%	$666K-16.5%	$798K
Operating Income	-$663K-1194.9%	$61K-79.9%	$301K+126.0%	$133K-64.8%	$378K+161.1%	$145K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0-100.0%	$3K-40.8%	$4K	$0	$0
Net Income	-$638K-670.8%	$112K-66.6%	$335K+124.8%	$149K-61.0%	$383K+125.8%	$169K
EPS (Diluted)	$-0.07-800.0%	$0.01-66.7%	$0.03+200.0%	$0.01-75.0%	$0.04+100.0%	$0.02

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Revenue	$1.2M+9.6%	$1.1M+11.3%	$1.0M-16.9%	$1.2M+6.2%	$1.2M+17.1%	$986K-14.6%	$1.2M+8.1%	$1.1M
Cost of Revenue	$181K+11.9%	$162K+8.4%	$149K-4.4%	$156K+4.0%	$150K+10.9%	$135K-17.2%	$163K+22.2%	$134K
Gross Profit	$1.1M+9.3%	$972K+11.8%	$870K-18.8%	$1.1M+6.5%	$1.0M+18.1%	$851K-14.2%	$991K+6.1%	$934K
R&D Expenses	$455K+7.3%	$424K-0.9%	$428K+3.8%	$412K+15.5%	$357K-14.9%	$419K+35.9%	$309K+24.7%	$247K
SG&A Expenses	$168K-18.4%	$206K-47.8%	$395K+160.9%	$151K-5.4%	$160K-22.1%	$205K+38.8%	$148K-53.0%	$314K
Operating Income	$79K+201.9%	-$77K+75.0%	-$309K-381.2%	$110K-9.2%	$121K+183.0%	-$145K-161.1%	$238K+144.2%	$97K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	$84K+215.7%	-$72K+76.1%	-$302K-355.7%	$118K-12.1%	$134K+203.4%	-$130K-152.1%	$250K+133.1%	$107K
EPS (Diluted)	$0.01+200.0%	$-0.01+66.7%	$-0.03-400.0%	$0.010.0%	$0.01+200.0%	$-0.01-150.0%	$0.02+100.0%	$0.01

DSNY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.0M-19.6%	$3.7M-5.1%	$3.9M+8.9%	$3.6M-7.7%	$3.9M+1.5%	$3.8M
Current Assets	$2.2M-7.9%	$2.4M-9.0%	$2.6M-4.7%	$2.7M-17.6%	$3.3M+4.9%	$3.2M
Cash & Equivalents	$1.1M-24.5%	$1.5M-26.0%	$2.0M-4.4%	$2.1M-23.9%	$2.8M+49.5%	$1.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$863K+26.8%	$681K+57.5%	$433K-10.6%	$484K+20.9%	$400K-6.2%	$427K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$544K+4.1%	$523K+26.9%	$412K-9.8%	$457K-38.9%	$748K-21.2%	$950K
Current Liabilities	$544K+4.1%	$523K+26.9%	$412K-9.8%	$457K-38.9%	$748K+2.4%	$731K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.4M-23.5%	$3.2M-8.9%	$3.5M+11.7%	$3.1M-0.3%	$3.1M+9.0%	$2.9M
Retained Earnings	-$5.8M-12.3%	-$5.2M+2.1%	-$5.3M+5.9%	-$5.6M+2.6%	-$5.8M+6.2%	-$6.2M

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Total Assets	$3.0M-8.9%	$3.3M+0.5%	$3.2M-10.7%	$3.6M-1.6%	$3.7M-0.7%	$3.7M-6.6%	$4.0M+2.4%	$3.9M
Current Assets	$2.3M+6.3%	$2.2M+3.1%	$2.1M-12.3%	$2.4M+2.4%	$2.4M+2.4%	$2.3M-11.0%	$2.6M-0.1%	$2.6M
Cash & Equivalents	$1.4M+8.0%	$1.3M+3.7%	$1.2M-20.3%	$1.5M+3.0%	$1.5M-3.8%	$1.5M-16.0%	$1.8M-8.5%	$2.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$890K+20.8%	$737K+1.3%	$727K+0.6%	$723K+6.1%	$681K+7.4%	$634K+1.9%	$623K+44.0%	$433K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$497K+24.9%	$398K-9.0%	$437K-2.2%	$447K-14.5%	$523K+26.2%	$414K-2.3%	$424K+2.9%	$412K
Current Liabilities	$497K+24.9%	$398K-9.0%	$437K-2.2%	$447K-14.5%	$523K+26.2%	$414K-2.3%	$424K+2.9%	$412K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.5M-13.6%	$2.9M+2.0%	$2.8M-11.9%	$3.2M+0.5%	$3.2M-4.1%	$3.3M-7.1%	$3.6M+2.3%	$3.5M
Retained Earnings	-$5.7M-5.5%	-$5.4M-1.3%	-$5.4M-6.0%	-$5.1M+2.3%	-$5.2M-0.1%	-$5.2M-2.6%	-$5.1M+4.7%	-$5.3M

DSNY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$65K-84.8%	$429K-39.2%	$706K+129.7%	$307K-41.9%	$529K+94.3%	$272K
Capital Expenditures	$29K+257.0%	$8K-98.6%	$586K+79.4%	$326K+629.0%	$45K-30.1%	$64K
Free Cash Flow	$36K-91.4%	$421K+250.5%	$120K+727.6%	-$19K-104.0%	$484K+132.6%	$208K
Investing Cash Flow	-$335K+30.8%	-$484K+32.3%	-$716K-3.3%	-$693K-217.3%	$591K+236.2%	-$434K
Financing Cash Flow	$0+100.0%	-$470K-2125.1%	-$21K+88.9%	-$191K+26.8%	-$260K+51.2%	-$533K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0-100.0%	$470K+2125.1%	$21K-88.2%	$179K-31.1%	$260K-51.2%	$533K

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Operating Cash Flow	$299K+227.2%	$91K+153.7%	-$170K-178.1%	$218K+57.5%	$138K+346.8%	-$56K-129.7%	$189K-4.6%	$198K
Capital Expenditures	$325-94.9%	$6K-65.2%	$18K+321.2%	$4K+105.0%	-$87K-418.1%	$27K+17.0%	$23K-95.9%	$566K
Free Cash Flow	$298K+251.2%	$85K+145.1%	-$188K-188.2%	$213K+315.8%	$51K+161.6%	-$83K-150.3%	$165K+144.9%	-$368K
Investing Cash Flow	-$30K+66.8%	-$91K+28.2%	-$126K-30.4%	-$97K-57.8%	-$61K+41.0%	-$104K+41.3%	-$177K-2406.0%	-$7K
Financing Cash Flow	$0	$0	$0	$0	$0+100.0%	-$136K+20.4%	-$171K-924.3%	-$17K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$0	$0	$0	$0	$0-100.0%	$136K-20.4%	$171K+924.3%	$17K

DSNY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	84.8%-1.4pp	86.2%-1.0pp	87.2%+3.5pp	83.7%-6.9pp	90.6%-1.1pp	91.7%
Operating Margin	-14.7%-16.0pp	1.4%-6.1pp	7.5%+4.2pp	3.3%-5.8pp	9.1%+5.3pp	3.8%
Net Margin	-14.1%-16.6pp	2.5%-5.8pp	8.3%+4.6pp	3.7%-5.5pp	9.2%+4.7pp	4.4%
Return on Equity	N/A	3.5%-6.1pp	9.7%+4.9pp	4.8%-7.5pp	12.3%+6.3pp	5.9%
Return on Assets	-21.5%-24.5pp	3.0%-5.6pp	8.6%+4.4pp	4.2%-5.7pp	9.9%+5.4pp	4.5%
Current Ratio	4.00-0.5	4.52-1.8	6.30+0.3	5.96+1.5	4.42+0.1	4.32
Debt-to-Equity	0.22+0.1	0.17+0.0	0.12-0.0	0.15-0.1	0.24-0.1	0.33
FCF Margin	0.8%-8.7pp	9.5%+6.5pp	3.0%+3.5pp	-0.5%-12.1pp	11.6%+6.2pp	5.4%

Metric	Q1'25	Q3'25	Q2'25	Q1'24	Q3'24	Q2'24	Q1'23	Q3'23
Gross Margin	85.4%-0.3pp	85.7%+0.4pp	85.4%-1.9pp	87.3%+0.3pp	87.0%+0.7pp	86.3%+0.4pp	85.9%-1.6pp	87.5%
Operating Margin	6.3%+13.1pp	-6.8%+23.5pp	-30.3%-39.2pp	8.9%-1.5pp	10.4%+25.2pp	-14.8%-35.4pp	20.6%+11.5pp	9.1%
Net Margin	6.7%+13.1pp	-6.4%+23.3pp	-29.6%-39.3pp	9.6%-2.0pp	11.6%+24.8pp	-13.2%-34.8pp	21.6%+11.6pp	10.0%
Return on Equity	3.4%	N/A	N/A	3.7%-0.4pp	4.1%	N/A	7.0%+3.9pp	3.1%
Return on Assets	2.8%+5.0pp	-2.2%+7.1pp	-9.3%-12.6pp	3.3%-0.4pp	3.6%+7.1pp	-3.5%-9.8pp	6.3%+3.5pp	2.7%
Current Ratio	4.69-0.8	5.50+0.6	4.86-0.6	5.42+0.9	4.52-1.1	5.58-0.5	6.12-0.2	6.30
Debt-to-Equity	0.20+0.1	0.14-0.0	0.16+0.0	0.14-0.0	0.17+0.0	0.130.0	0.120.0	0.12
FCF Margin	24.0%+16.5pp	7.5%+26.0pp	-18.5%-35.9pp	17.4%+7.5pp	9.9%+18.3pp	-8.4%-22.8pp	14.3%+5.8pp	8.5%

Similar Companies

Acadia Energy Corporation AECX

$5.0M

Peer To Peer Net PTOP

$4.8M

Sparta Coml Svcs Inc SRCO

$4.6M

Liveworld LVWD

$5.5M

Xinda Intl XNDA

$4.6M

Frequently Asked Questions

What is Destiny Meda Tec's annual revenue?

Destiny Meda Tec (DSNY) reported $4.5M in total revenue for fiscal year 2025. This represents a 2.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Destiny Meda Tec's revenue growing?

Destiny Meda Tec (DSNY) revenue grew by 2.3% year-over-year, from $4.4M to $4.5M in fiscal year 2025.

Is Destiny Meda Tec profitable?

No, Destiny Meda Tec (DSNY) reported a net income of -$638K in fiscal year 2025, with a net profit margin of -14.1%.

What is Destiny Meda Tec's earnings per share (EPS)?

Destiny Meda Tec (DSNY) reported diluted earnings per share of $-0.07 for fiscal year 2025. This represents a -800.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Destiny Meda Tec's EBITDA?

Destiny Meda Tec (DSNY) had EBITDA of $171K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Destiny Meda Tec's gross margin?

Destiny Meda Tec (DSNY) had a gross margin of 84.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Destiny Meda Tec's operating margin?

Destiny Meda Tec (DSNY) had an operating margin of -14.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Destiny Meda Tec's net profit margin?

Destiny Meda Tec (DSNY) had a net profit margin of -14.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Destiny Meda Tec's free cash flow?

Destiny Meda Tec (DSNY) generated $36K in free cash flow during fiscal year 2025. This represents a -91.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Destiny Meda Tec's operating cash flow?

Destiny Meda Tec (DSNY) generated $65K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Destiny Meda Tec's total assets?

Destiny Meda Tec (DSNY) had $3.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Destiny Meda Tec's capital expenditures?

Destiny Meda Tec (DSNY) invested $29K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Destiny Meda Tec spend on research and development?

Destiny Meda Tec (DSNY) invested $1.8M in research and development during fiscal year 2025.

How many shares does Destiny Meda Tec have outstanding?

Destiny Meda Tec (DSNY) had 10M shares outstanding as of fiscal year 2025.

What is Destiny Meda Tec's current ratio?

Destiny Meda Tec (DSNY) had a current ratio of 4.00 as of fiscal year 2025, which is generally considered healthy.

What is Destiny Meda Tec's debt-to-equity ratio?

Destiny Meda Tec (DSNY) had a debt-to-equity ratio of 0.22 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Destiny Meda Tec's return on assets (ROA)?

Destiny Meda Tec (DSNY) had a return on assets of -21.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Destiny Meda Tec's Piotroski F-Score?

Destiny Meda Tec (DSNY) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Destiny Meda Tec's earnings high quality?

Destiny Meda Tec (DSNY) has an earnings quality ratio of -0.10x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Destiny Meda Tec?

Destiny Meda Tec (DSNY) scores 48 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.